TM-Flow Hardware

Our TM-Flow ANS testing medical device is a highly comprehensive, user-friendly, non-invasive tool that focuses on early detection and follow-up of complications (Autonomic Nervous System & Vascular System) by measuring 8 health risk areas within the body. This ANS testing medical device effectively measures the state of a patient’s health by screening for hidden causes of disease and other chronic metabolic diseases such as diabetes and other cardiometabolic risks.

How does the TM-Flow medical device assess

the Autonomic Nervous System?

The TM-Flow medical device Scan analyzes the Photoplethysmography ( PTG) waveform to precisely and accurately detect the beat-to-beat heart rate (RR-intervals). While lying and standing, the blood pressure is measured by oscillometry (TM-Flow) or by volume plethysmography. The sudomotor function is assessed by a galvanic skin response device either using metal plates following the electrical stimulation of the sweat glands (ANS-1) or disposable cloth electrodes and pressure cuffs placed on the ankles following a double stimulation - the metaboreflex and the electrical stimulation of the sweat glands (TM-Flow).

HOW DOES THE TM-FLOW MEDICAL DEVICE ASSESS VASCULAR DYSFUNCTION? ESTABLISHING THE MEDICAL NECESSITY FOR ORDERING THIS TEST FOLLOWS A VAST ARRAY OF POTENTIAL SYMPTOMS.

The TM-Flow medical device Scan analyzes the Photoplethysmography (PTG), and volume plethysmography recordings from segmental pressures of the upper and lower extremities. Volume Plethysmography is a technique that records the large artery blood flow with pressure cuffs and pumps.

Our volume plethysmography analysis provides markers of arterial stiffness, which are Brachial- Ankle Pulse Wave Velocity, peripheral Augmentation Index, and Central Aortic Systolic Pressure.

Segmental pressures of the upper and lower extremities allow for calculating the Ankle-Brachial Indices to diagnose PAD.

PTG is a technique that records the peripheral circulation using infrared light with our oximeter.

THE NON-INVASIVE METHODS UTILIZED BY THE TM-FLOW DEVICE

FOR ASSESSING VASCULAR FUNCTION COMPRISED OF

Carotid artery ultrasound

Peripheral artery ultrasound

Volume plethysmography recordings

Photoplethysmography recordings

Segmental pressures of the upper and lower extremities

TCP02 testing

THE TM-FLOW MEDICAL DEVICE OVERVIEW

Our TM-Flow ANS testing platform is a Medical Device Data System that uses all four LD Technologies to identify the different Markers that demonstrate the Patient Health Conditions.

ASSESSMENTS

Cardiac Autonomic Neuropathy

Sudomotor

Endothelial Dysfunction

Ankle-brachial Indices

Lifestyle

Cardiometabolic Risk Score

HOW

Guidelines of the CAN Subcommittee of the Toronto Consensus Panel Statement.

The Patented sequence of electrical stimulation measured at negative and positive electrodes.

The Patented analysis of the PTG spectral analysis and vasomotion.

Synchronization of 4 Bluetooth BP devices and Heart association guidance.

Fat Mass by BIA Vital signs and HRV markets.

Based on Abnormal results of all the CMAT markers.

WHY? CLINICAL OUTCOMES

CAN is a high-risk factor of CVD and hypoglycemia (Hb1Ac target).

Early detection of Small fiber Neuropathy and adapted treatment options.

Insulin resistance Inflammation Thrombotic Risk Vasodilation Responses Blood flow.

Early detection of Peripheral artery disease and treatment options.

Visualization and evaluation of the lifestyle changes.

Treatment follow-up and early detection of micro and/or macrovascular complications.